Surgical treatment of liver cancer and pancreatic cancer under the China Healthcare Security Diagnosis Related Groups payment system

doi:10.12998/wjcc.v12.i21.4673

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 21

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-2)

Sum=0

Jul 26, 2024 (publication date) through Jun 30, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Evidence-Based Medicine

World J Clin Cases. Jul 26, 2024; 12(21): 4673-4679
Published online Jul 26, 2024. doi: 10.12998/wjcc.v12.i21.4673

Surgical treatment of liver cancer and pancreatic cancer under the China Healthcare Security Diagnosis Related Groups payment system

Yun-He Hu, Fan Yu, Yu-Zhuo Zhou, Ai-Dong Li

Yun-He Hu, Fan Yu, Yu-Zhuo Zhou, Ai-Dong Li, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China

Author contributions: Hu YH, Yu F, Zhou YZ and Li AD contributed equally to this work; Hu YH and Li AD were the guarantors of the integrity of the entire study; Hu YH performed the study concept and design; Hu YH, Yu F, Zhou YZ prepared and wrote the manuscript; all authors have access to the data and played a role in writing this manuscript.

Supported by Research Center for Capital Health Management and Policy, No. 2024JD09.

Conflict-of-interest statement: Dr. Li has nothing to disclose.

PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https: //creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Ai-Dong Li, Associate Research Scientist, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan South Lane, Chaoyang District, Beijing 100021, China. aidong_li1208@sina.com

Received: April 30, 2024
Revised: June 6, 2024
Accepted: June 7, 2024
Published online: July 26, 2024
Processing time: 61 Days and 2.5 Hours

Core Tip

Core Tip: To analyze cost differences and their influencing factors in surgical treatments for liver and pancreatic cancer within the China Healthcare Security Diagnosis Related Groups (CHS-DRG) payment system, this study aims to examine the appropriateness of the current diagnosis-related groups groupings and provide recommendations for improvement. The CHS-DRG payment system has shown a positive impact on the surgical treatment of liver and pancreatic cancer by enhancing medical quality and managing costs. However, additional research is necessary to refine the grouping system and ensure its continued effectiveness and sustainability.